FDA approves weight-loss drug Zepbound to treat sleep apnea – The Washington Post

Business News

  1. FDA approves weight-loss drug Zepbound to treat sleep apnea  The Washington Post
  2. FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and Company
  3. F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea  The New York Times
  4. Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.  STAT
  5. FDA approves weight-loss drug Zepbound for obstructive sleep apnea  CNN

Source: Business News

/by